道瓊斯指數
51,608.17
漲跌
-739.38-1.41%
在 MEXC 探索美國生物科技板塊股票,涵蓋專注於藥物研發、基因治療及生物學研究的公司。比較股價、當日漲跌、市值和成交量,全面瞭解生物科技行業動態。

今日美股市場整體下跌,道瓊斯指數下跌 1.41%,標普 500 指數下跌 1.92%,納斯達克綜合指數下跌 2.49%。市場廣度偏弱,4,080 隻股票下跌、1,036 隻上漲,整體呈現偏空格局。
| # | 股票 | 52 週價格區間 | |||||
|---|---|---|---|---|---|---|---|
| 1 | 安進AMGN | $463.48 | -0.29% | 779.25K | $250.70B | $312.38 - $483.99 | 0.02% |
| 2 | 吉利德科學GILD | $167.59 | -0.10% | 1.90M | $207.87B | $116.88 - $176.58 | 0.02% |
| 3 | ModernaMRNA | $216.02 | -2.93% | 4.52M | $87.41B | $22.28 - $280.80 | 0.00% |
| 4 | IQVIA HoldingsIQV | $264.92 | +0.05% | 823.00K | $43.66B | $154.50 - $284.50 | 0.00% |
| 5 | BiogenBIIB | $252.71 | -0.37% | 357.76K | $37.35B | $160.36 - $261.00 | 0.00% |
| 6 | Revolution MedRVMD | $167.04 | -3.15% | 1.64M | $36.13B | $67.27 - $224.31 | 0.00% |
| 7 | 英賽德INCY | $120.16 | -0.55% | 662.39K | $24.49B | $89.25 - $132.60 | 0.00% |
| 8 | Medpace HoldingsMEDP | $652.39 | -0.23% | 142.86K | $18.25B | $373.00 - $693.97 | 0.00% |
| 9 | NeurocrineNBIX | $165.76 | -1.36% | 706.56K | $16.78B | $122.14 - $186.12 | 0.00% |
| 10 | ExelixisEXEL | $67.58 | -2.01% | 984.92K | $16.49B | $39.71 - $73.69 | 0.00% |
| 11 | Charles River Laboratories IntlCRL | $335.65 | -0.72% | 295.90K | $16.08B | $146.19 - $379.63 | 0.00% |
| 12 | Bio-TechneTECH | $72.78 | -0.02% | 2.07M | $11.43B | $43.20 - $72.88 | 0.00% |
| 13 | Halozyme TherapHALO | $97.22 | -3.08% | 1.13M | $11.08B | $61.23 - $134.00 | 0.00% |
| 14 | KymeraKYMR | $124.43 | -2.04% | 490.10K | $10.62B | $62.91 - $142.92 | 0.00% |
| 15 | Repligen CorpRGEN | $163.97 | -2.16% | 257.30K | $10.48B | $100.99 - $198.87 | 0.00% |
| 16 | VaxcytePCVX | $62.03 | -1.88% | 334.98K | $9.82B | $42.40 - $90.75 | 0.00% |
| 17 | Krystal BiotechKRYS | $296.64 | -2.79% | 80.09K | $8.79B | $202.99 - $382.54 | 0.00% |
| 18 | CG OncologyCGON | $84.99 | +15.81% | 7.10M | $7.59B | $37.01 - $106.36 | 0.00% |
| 19 | ImmunovantIMVT | $33.28 | -2.37% | 380.82K | $6.89B | $21.86 - $45.42 | 0.00% |
| 20 | Twist BioscienceTWST | $105.08 | -5.50% | 1.61M | $6.59B | $24.41 - $219.71 | 0.00% |
| 21 | Kodiak SciencesKOD | $102.15 | -7.33% | 668.72K | $6.42B | $18.14 - $113.03 | 0.00% |
| 22 | ImmunitybioIBRX | $6.01 | +0.42% | 9.23M | $6.40B | $1.95 - $12.43 | 0.00% |
| 23 | Scholar RockSRRK | $44.77 | +1.65% | 1.57M | $5.46B | $35.53 - $61.76 | 0.00% |
| 24 | Adaptive BiotechnologiesADPT | $27.94 | -3.37% | 1.46M | $4.52B | $12.00 - $32.21 | 0.00% |
| 25 | Crispr TherapeuticsCRSP | $40.43 | -3.68% | 1.08M | $3.92B | $40.39 - $63.45 | 0.00% |
| 26 | 雷利療法RLAY | $17.48 | -2.87% | 664.56K | $3.86B | $6.17 - $21.27 | 0.00% |
| 27 | TarsusTARS | $78.05 | -2.86% | 343.65K | $3.85B | $53.89 - $91.53 | 0.00% |
| 28 | Iovance BiotherapeuticsIOVA | $7.61 | -1.35% | 5.46M | $3.52B | $2.08 - $15.37 | 0.00% |
| 29 | ADMA Biologics IncADMA | $13.61 | -0.11% | 1.81M | $3.02B | $7.21 - $20.46 | 0.00% |
| 30 | Denali TherapeuticsDNLI | $18.34 | -1.55% | 485.00K | $2.94B | $15.34 - $27.30 | 0.00% |
| 31 | Vericel Corp OrdVCEL | $57.43 | +0.54% | 573.59K | $2.93B | $28.95 - $59.75 | 0.00% |
| 32 | BeamBEAM | $21.25 | -6.46% | 1.58M | $2.20B | $20.23 - $38.26 | 0.00% |
| 33 | ReplimuneREPL | $21.49 | -1.37% | 1.27M | $2.04B | $1.50 - $23.54 | 0.00% |
| 34 | BioCryst PharmaBCRX | $7.54 | -0.72% | 2.67M | $1.94B | $6.23 - $11.22 | 0.00% |
| 35 | Hemab TherapeuticsCOAG | $38.98 | -4.60% | 272.83K | $1.91B | $23.00 - $55.42 | 0.00% |
| 36 | Maze TherapeuticsMAZE | $34.09 | -0.61% | 317.15K | $1.88B | $21.95 - $53.65 | 0.00% |
| 37 | Recursion PharmaceuticalsRXRX | $2.90 | -8.95% | 16.56M | $1.81B | $2.77 - $5.24 | 0.00% |
| 38 | Vir BiotechVIR | $9.72 | -1.86% | 2.69M | $1.67B | $5.32 - $14.38 | 0.00% |
| 39 | Taysha GeneTSHA | $4.07 | -0.85% | 1.36M | $1.33B | $3.46 - $7.30 | 0.00% |
| 40 | NovavaxNVAX | $8.03 | -5.69% | 2.78M | $1.33B | $6.20 - $13.38 | 0.00% |
| 41 | AbsciABSI | $7.57 | -9.17% | 5.24M | $1.31B | $2.24 - $12.54 | 0.00% |
| 42 | Vor BiopharmaVOR | $19.27 | -0.41% | 376.63K | $1.18B | $6.50 - $26.00 | 0.00% |
| 43 | Inhibrx BiosciencesINBX | $78.34 | -7.29% | 195.39K | $1.15B | $57.30 - $155.29 | 0.00% |
| 44 | Odyssey TherapeuticsODTX | $19.21 | +0.47% | 211.04K | $920.02M | $15.10 - $29.05 | 0.00% |
| 45 | MeiraGTxMGTX | $8.87 | -3.32% | 400.74K | $866.87M | $6.62 - $15.35 | 0.00% |
| 46 | Monte Rosa TherapeuticsGLUE | $9.19 | -1.81% | 457.75K | $785.03M | $8.95 - $25.77 | 0.00% |
| 47 | Prime MedicinePRME | $4.28 | +0.35% | 4.34M | $775.39M | $2.67 - $5.91 | 0.00% |
| 48 | Aura BiosciencesAURA | $7.23 | +1.83% | 446.17K | $752.67M | $4.73 - $9.54 | 0.00% |
| 49 | Solid BiosciencesSLDB | $6.57 | -3.73% | 539.28K | $732.72M | $4.16 - $11.45 | 0.00% |
| 50 | OmniAbOABI | $4.91 | +0.41% | 497.96K | $715.44M | $1.35 - $5.45 | 0.00% |
| 現貨美股(RealStocks) | 代幣化美股(Tokenized Stocks) | 股票合約(Stock Futures) | |
|---|---|---|---|
| 是什麼 | 美股上市公司的真實股份(現貨美股) | 與美股/ETF 掛鉤的區塊鏈代幣 | 以 USDT 保證金進行的股價合約交易 |
| 所有權 | 是 —— 真實持股 | 否 —— 僅為合成敞口 | 否 —— 僅為衍生品敞口 |
| 股東權益 | 有(如分紅) | 無 | 無 |
| 交易時間 | 美股交易時段(盤前、正常、盤後、隔夜) | 24/7 全天候 | 支援交易對最高可達 24/7 全天候 |
| 持倉方式 | 買入並持有 | 買入並持有 | 支援多空雙向、槓桿交易 |
| 適合人群 | 追求長期持有和分紅收益的投資者 | 希望全天候獲得股票敞口、無需持有股票的交易者 | 希望通過槓桿進行投機或對沖的短線/活躍交易者 |
通過 MEXC 合作的持牌券商購買真實美股,並可按適用條件享有股息等股東權益。
覆蓋 7,000+ 隻美國上市股票及 ETF,涵蓋科技、金融、醫療、消費等多個行業。
支持 USDT 轉入及 USDT/USD 轉換,更便捷地為 RealStocks 帳戶提供資金。
以具有競爭力的交易成本參與真實美股交易,讓更多資金用於投資策略。
本頁面展示的美股價格、指數、排行榜、圖表及其他市場數據可能來自第三方數據提供商,並可能存在延遲或誤差。MEXC 提供的相關信息僅供參考和教育用途,不對其準確性或完整性作出保證。頁面內容不構成任何金融或投資建議,也不構成買賣任何證券的推薦。美股交易存在風險,歷史表現不代表未來結果,用戶應在作出投資決定前進行獨立研究。